Cargando…

The ensured proliferative capacity of myoblast in serum-reduced conditions with Methyl-β-cyclodextrin

To produce muscle fibers for cultured meat on a large scale, it is important to expand myoblasts in a serum-reduced or serum-free medium to avoid cost, ethical, and environmental issues. Myoblasts such as C2C12 cells differentiate quickly into myotubes and lose their ability to proliferate when the...

Descripción completa

Detalles Bibliográficos
Autores principales: Katayama, Tomoka, Chigi, Yuta, Okamura, Daiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213241/
https://www.ncbi.nlm.nih.gov/pubmed/37250904
http://dx.doi.org/10.3389/fcell.2023.1193634
_version_ 1785047575423877120
author Katayama, Tomoka
Chigi, Yuta
Okamura, Daiji
author_facet Katayama, Tomoka
Chigi, Yuta
Okamura, Daiji
author_sort Katayama, Tomoka
collection PubMed
description To produce muscle fibers for cultured meat on a large scale, it is important to expand myoblasts in a serum-reduced or serum-free medium to avoid cost, ethical, and environmental issues. Myoblasts such as C2C12 cells differentiate quickly into myotubes and lose their ability to proliferate when the serum-rich medium is replaced with a serum-reduced medium. This study demonstrates that Methyl-β-cyclodextrin (MβCD), a starch-derived agent that depletes cholesterol, can inhibit further differentiation of myoblasts at the MyoD-positive stage by reducing plasma membrane cholesterol on C2C12 cells and primary cultured chick muscle cells. Furthermore, MβCD efficiently blocks cholesterol-dependent apoptotic cell death of myoblasts, which is one of the mechanisms by which it inhibits the differentiation of C2C12 myoblast cells, as dead cells of myoblast are necessary for the fusion of adjacent myoblasts during the differentiation process into myotubes. Importantly, MβCD maintains the proliferative capacity of myoblasts only under differentiation conditions with a serum-reduced medium, suggesting that its mitogenic effect is due to its inhibitory effect on myoblast differentiation into myotube. In conclusion, this study provides significant insights into ensuring the proliferative capacity of myoblasts in a future serum-free condition for cultured meat production.
format Online
Article
Text
id pubmed-10213241
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102132412023-05-27 The ensured proliferative capacity of myoblast in serum-reduced conditions with Methyl-β-cyclodextrin Katayama, Tomoka Chigi, Yuta Okamura, Daiji Front Cell Dev Biol Cell and Developmental Biology To produce muscle fibers for cultured meat on a large scale, it is important to expand myoblasts in a serum-reduced or serum-free medium to avoid cost, ethical, and environmental issues. Myoblasts such as C2C12 cells differentiate quickly into myotubes and lose their ability to proliferate when the serum-rich medium is replaced with a serum-reduced medium. This study demonstrates that Methyl-β-cyclodextrin (MβCD), a starch-derived agent that depletes cholesterol, can inhibit further differentiation of myoblasts at the MyoD-positive stage by reducing plasma membrane cholesterol on C2C12 cells and primary cultured chick muscle cells. Furthermore, MβCD efficiently blocks cholesterol-dependent apoptotic cell death of myoblasts, which is one of the mechanisms by which it inhibits the differentiation of C2C12 myoblast cells, as dead cells of myoblast are necessary for the fusion of adjacent myoblasts during the differentiation process into myotubes. Importantly, MβCD maintains the proliferative capacity of myoblasts only under differentiation conditions with a serum-reduced medium, suggesting that its mitogenic effect is due to its inhibitory effect on myoblast differentiation into myotube. In conclusion, this study provides significant insights into ensuring the proliferative capacity of myoblasts in a future serum-free condition for cultured meat production. Frontiers Media S.A. 2023-05-12 /pmc/articles/PMC10213241/ /pubmed/37250904 http://dx.doi.org/10.3389/fcell.2023.1193634 Text en Copyright © 2023 Katayama, Chigi and Okamura. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cell and Developmental Biology
Katayama, Tomoka
Chigi, Yuta
Okamura, Daiji
The ensured proliferative capacity of myoblast in serum-reduced conditions with Methyl-β-cyclodextrin
title The ensured proliferative capacity of myoblast in serum-reduced conditions with Methyl-β-cyclodextrin
title_full The ensured proliferative capacity of myoblast in serum-reduced conditions with Methyl-β-cyclodextrin
title_fullStr The ensured proliferative capacity of myoblast in serum-reduced conditions with Methyl-β-cyclodextrin
title_full_unstemmed The ensured proliferative capacity of myoblast in serum-reduced conditions with Methyl-β-cyclodextrin
title_short The ensured proliferative capacity of myoblast in serum-reduced conditions with Methyl-β-cyclodextrin
title_sort ensured proliferative capacity of myoblast in serum-reduced conditions with methyl-β-cyclodextrin
topic Cell and Developmental Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213241/
https://www.ncbi.nlm.nih.gov/pubmed/37250904
http://dx.doi.org/10.3389/fcell.2023.1193634
work_keys_str_mv AT katayamatomoka theensuredproliferativecapacityofmyoblastinserumreducedconditionswithmethylbcyclodextrin
AT chigiyuta theensuredproliferativecapacityofmyoblastinserumreducedconditionswithmethylbcyclodextrin
AT okamuradaiji theensuredproliferativecapacityofmyoblastinserumreducedconditionswithmethylbcyclodextrin
AT katayamatomoka ensuredproliferativecapacityofmyoblastinserumreducedconditionswithmethylbcyclodextrin
AT chigiyuta ensuredproliferativecapacityofmyoblastinserumreducedconditionswithmethylbcyclodextrin
AT okamuradaiji ensuredproliferativecapacityofmyoblastinserumreducedconditionswithmethylbcyclodextrin